2012 News | Events | Industry Updates
Selcia Limited, the global provider of contract research services to the life sciences industry, has today announced the demerger of all internally generated intellectual property into two new companies, Mitopharm Ltd and Selcia Pharma Ltd.
An article by Bob Carling at Selcia Ltd. on Screening Techniques for Fragment-Based Drug Discovery has been published in Innovations in Pharmaceutical Technology (IPT) magazine.
The 20th anniversary is a fitting acknowledgement of success for Selcia’s Radiolabelling Division which has seen turnover increase year on year since the company was founded in 2005.
Fragment Screening Using Capillary Electrophoresis (CEfrag) for Hit Identification of Heat Shock Protein 90 ATPase Inhibitors
J Biomol Screen May 9, 2012 doi 10.1177/1087057112445785
Sp2 Magazine has published an article in its recent issue showcasing Selcia's successful Drug Discovery and Radiolabelling divisions.